Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Extension of TKT024: Long-Term Idursulfase in MPS II
2004-002743-27Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2004
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of idursulfase in mucopolysaccharidosis type 2, sponsored by Takeda. Started Nov 2004; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on 2004-002743-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002743-27.